3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Odontogenic Cysts
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Metastatic Castration-resistant Prostate Cancer
1
Lung Neoplasms
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Neuroendocrine
1
Anus Neoplasms
1
Interventions
Hepatectomy
10
Blood Specimen Collection
9
Sorafenib
7
Polymerase Chain Reaction
4
Biopsy
4
regorafenib
3
Mass Spectrometry
3
Liver Transplantation
3
Immunohistochemistry
3
Chemoembolization, Therapeutic
3
Walking Speed
2
Surveys and Questionnaires
2
Psychiatric Rehabilitation
2
Magnetic Resonance Imaging
2
Gene Expression Profiling
2
Bevacizumab
2
trastuzumab deruxtecan
1
taxane
1
spartalizumab
1
sintilimab
1
lenvatinib
1
gadolinium ethoxybenzyl DTPA
1
donafenib
1
carmofur
1
camrelizumab
1
cabozantinib
1
atezolizumab
1
apatinib
1
anlotinib
1
Yttrium-90
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Liver Neoplasms
×
Radionuclide Imaging
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled